RECENT NEWS

Scottish Brain Sciences (SBS) has launched a new and accredited clinical laboratory service offering blood‑based biomarker and cerebrospinal fluid (CSF) testing for Alzheimer’s disease. The service increases Scotland’s capacity to provide faster, more accurate and more accessible diagnostic support for clinicians and healthcare providers across the UK.

LotusDx, a medtech company developing at-home diagnostic tests for sexually transmitted infections (STIs), has established its R&D laboratory at ONE BioHub, located on the Foresterhill Health Campus, in Aberdeen.

Leica Biosystems has announced the expansion of a collaboration to scale precision medicine and develop AI-powered diagnostics. The Danaher company is working with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 NMR in non-small cell lung cancer.

In a first for the field, all non-human primates given a new series of vaccines generated antibodies capable of fighting multiple strains of HIV.

Roche has announced the launch of its comprehensive Liver Disease Panel, a suite of certified algorithms designed to help clinicians better identify and manage chronic liver disease (CLD).

Leica Biosystems has entered into a new commercial partnership with DiaDeep, a Lyon-based company specialising in medical AI for oncology pathology, which will see DiaDeep’s AI applications available through the Aperio AI Store.

Molecular diagnostics firm Co-Diagnostics has announced that it has completed the assay development strategy for the Bundibugyo virus (BDBV) currently causing an outbreak of Ebola disease in the Democratic Republic of the Congo and Uganda.

SLAS, the Society of Laboratory Automation and Screening, welcomed 137 exhibitors and more than 1,500 registrants from more than 30 countries at its 2026 Europe Conference and Exhibition held in Vienna, Austria in May 2026.

Molecular diagnostics company Yourgene Health has launched its new Insight DPYD assay, an assay utilising genetic insights for safer chemotherapy treatments to align with updated testing guidelines.

A study led by researchers at Madrid's Centro Nacional de Investigaciones Cardiovasculares (CNIC) has identified a mitochondrial ‘checkpoint’ that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumours.

The first UKHSA One Health report tracks vector-borne diseases in England, with Lyme disease remaining the most common infection in 2025.

The World Health Organization (WHO) has declared that the current outbreak of Ebola disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda constitutes a public health emergency of international concern.

Leading infection specialty organisations across the UK have launched a new report calling for urgent action to support and strengthen and modernise the UK’s infection specialist workforce.

The Institute of Biomedical Science (IBMS) has published a new guidance document supporting the safe, ethical and transparent use of generative artificial intelligence (AI) across IBMS qualifications.

Creative data technology provider InterSystems has announced that its electronic health record (EHR) solutions have just become the first AI-native EHR to achieve EU MDR certification.

The NHS Modernisation Bill brought forward in the UK Parliament on Thursday 14 May will introduce the Single Patient Record, allowing fragmented health information to be joined up around the country, and will cut layers of bureaucracy so more time and money can be spent on frontline services.

A new report published by the UK Health Security Agency (UKHSA) shows that the trend in HIV diagnoses in England have continued to fall, with England meeting the UNAIDS 95-95-95 targets again.

Hundreds of thousands of babies will be screened as part of a new NIHR-funded trial evaluating newborn screening for spinal muscular atrophy (SMA).

More than 1,500 people a year with an aggressive form of stomach cancer are set to receive a new treatment available on the NHS, after NICE recommended durvalumab - the first immunotherapy for people with this form of cancer.

Precision medicine firm SOPHiA GENETICS has announced a partnership with Synnovis, one of England's leading pathology providers, to bring liquid biopsy testing to lung and breast cancer patients across the UK as part of NHS England's revolutionary ‘blood test-first' programme.